Automated Author ProfileLu, Jinsen
Lu, Jinsen
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 0.0 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
This is the supplementary data for the omics content mentioned in the ariticle named "Multiomic Profiling of Responses to Clinical and Novel Bisphosphonates Reveals Extraskeletal Effects on Ageing Related Signatures" submitted to STTT.The data including: 1. The raw count data for GeoMX DSP based RNAseq of organ in aged mice following zoledronate treatment (vs control)2.The raw count data for RNAseq on cardiac cell following zoldronate and vehicle treatment.3.The raw count data for ATACseq on cardiac cell following BPs and vehicle treatment.4.The SomaScan plasma proteomics output data for female osteopenic patient before and after zoledronate treatment for 18 and 36 months.5.The TMT-MS raw output data of CESTA-MS(2D-TPP) assay for zoledronate binding targets.
Authors
- Lu, Jinsen
This is the supplementary data for the omics content mentioned in the ariticle named "Multiomic Profiling of Responses to Clinical and Novel Bisphosphonates Reveals Extraskeletal Effects on Ageing Related Signatures" submitted to STTT.The data including: 1. The raw count data for GeoMX DSP based RNAseq of organ in aged mice following zoledronate treatment (vs control)2.The raw count data for RNAseq on cardiac cell following zoldronate and vehicle treatment.3.The raw count data for ATACseq on cardiac cell following BPs and vehicle treatment.4.The SomaScan plasma proteomics output data for female osteopenic patient before and after zoledronate treatment for 18 and 36 months.5.The TMT-MS raw output data of CESTA-MS(2D-TPP) assay for zoledronate binding targets.
Authors
- Lu, Jinsen